Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial
Jon-David Schwalm, Tara McCready, Patricio López‐Jaramillo, et al.
The Lancet (2019) Vol. 394, Iss. 10205, pp. 1231-1242
Closed Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1600
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Bin Zhou, Pablo Perel, George A. Mensah, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 11, pp. 785-802
Open Access | Times Cited: 984
Polypill with or without Aspirin in Persons without Cardiovascular Disease
Salim Yusuf, Philip Joseph, Antonio Dans, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 3, pp. 216-228
Open Access | Times Cited: 221
A Community-Based Intervention for Managing Hypertension in Rural South Asia
Tazeen H. Jafar, Mihir Gandhi, H. Asita de Silva, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 8, pp. 717-726
Open Access | Times Cited: 206
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
Philip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
The Lancet (2021) Vol. 398, Iss. 10306, pp. 1133-1146
Closed Access | Times Cited: 127
Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE)
Philip Joseph, Álvaro Avezum, Chinthanie Ramasundarahettige, et al.
Journal of the American College of Cardiology (2025) Vol. 85, Iss. 5, pp. 436-447
Closed Access | Times Cited: 4
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
Clara K Chow, Tu Ngoc Nguyen, Simone Marschner, et al.
BMJ Global Health (2020) Vol. 5, Iss. 11, pp. e002640-e002640
Open Access | Times Cited: 97
World Heart Federation Roadmap for Hypertension – A 2021 Update
Panniyammakal Jeemon, T. Séverin, Celso Amodeo, et al.
Global Heart (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 93
Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness
Gail L. Daumit, Arlene Dalcin, Faith Dickerson, et al.
JAMA Network Open (2020) Vol. 3, Iss. 6, pp. e207247-e207247
Open Access | Times Cited: 77
Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy
Patricio López‐Jaramillo, Philip Joseph, José López-López, et al.
European Heart Journal (2022) Vol. 43, Iss. 30, pp. 2841-2851
Closed Access | Times Cited: 66
Effectiveness of a primary care-based integrated mobile health intervention for stroke management in rural China (SINEMA): A cluster-randomized controlled trial
Lijing L. Yan, Enying Gong, Wanbing Gu, et al.
PLoS Medicine (2021) Vol. 18, Iss. 4, pp. e1003582-e1003582
Open Access | Times Cited: 62
Virtual management of hypertension: lessons from the COVID-19 pandemic–International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
Nadia Khan, George S. Stergiou, Stefano Omboni, et al.
Journal of Hypertension (2022) Vol. 40, Iss. 8, pp. 1435-1448
Closed Access | Times Cited: 41
Social Determinants of Health and Disparities in Hypertension and Cardiovascular Diseases
Abhishek Chaturvedi, Anqi Zhu, Naga Vaishnavi Gadela, et al.
Hypertension (2023) Vol. 81, Iss. 3, pp. 387-399
Open Access | Times Cited: 30
“We just have to help”: Community health workers' informal task-shifting and task-sharing practices for hypertension and diabetes care in Nigeria
Whenayon Simeon Ajisegiri, Ṣẹ̀yẹ Abímbọ́lá, Azeb Gebresilassie Tesema, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 25
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension
Xiaofan Guo, Nanxiang Ouyang, Guozhe Sun, et al.
JAMA Cardiology (2024) Vol. 9, Iss. 9, pp. 781-781
Open Access | Times Cited: 9
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Sarah Zaman, Jason H. Wasfy, Vikas Kapil, et al.
The Lancet (2025)
Closed Access | Times Cited: 1
Hypertension and race/ethnicity
Bradley Deere, Keith C. Ferdinand
Current Opinion in Cardiology (2020) Vol. 35, Iss. 4, pp. 342-350
Closed Access | Times Cited: 61
Task-sharing interventions for improving control of diabetes in low-income and middle-income countries: a systematic review and meta-analysis
Linju Joseph, T N Anand, Dona Boban, et al.
The Lancet Global Health (2020) Vol. 9, Iss. 2, pp. e170-e180
Open Access | Times Cited: 52
DP1 (Prostaglandin D 2 Receptor 1) Activation Protects Against Vascular Remodeling and Vascular Smooth Muscle Cell Transition to Myofibroblasts in Angiotensin II–Induced Hypertension in Mice
Fangdi Zou, Yong Li, Shijie Zhang, et al.
Hypertension (2022) Vol. 79, Iss. 6, pp. 1203-1215
Closed Access | Times Cited: 32
Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Diseases in CKD
Sadaf G Sepanlou, Johannes F.E. Mann, Philip Joseph, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 11, pp. 1408-1415
Open Access | Times Cited: 21
Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars)
Fatemeh Malekzadeh, Abdullah Gandomkar, Hossein Poustchi, et al.
Heart (2024) Vol. 110, Iss. 14, pp. 940-946
Closed Access | Times Cited: 8
Role of Health Care Professionals in the Success of Blood Pressure Control Interventions in Patients With Hypertension: A Meta-Analysis
Katherine T. Mills, Samantha O’Connell, Meng Pan, et al.
Circulation Cardiovascular Quality and Outcomes (2024) Vol. 17, Iss. 8
Closed Access | Times Cited: 6
Challenges in management and prevention of ischemic heart disease in low socioeconomic status people in LLMICs
Rajeev Gupta, Salim Yusuf
BMC Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 52
Standardized treatment to improve hypertension control in primary health care: The HEARTS in the Americas Initiative
Donald J. DiPette, Kenneth Goughnour, Eric Zúñiga, et al.
Journal of Clinical Hypertension (2020) Vol. 22, Iss. 12, pp. 2285-2295
Open Access | Times Cited: 43
Blood Pressure Tracking From Childhood to Adulthood
Tatsuhiko Azegami, Keiko Uchida, Mitsuaki Tokumura, et al.
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top